Cynosure (CYNO) Stock Price, News & Analysis

Company Overview

Cynosure, Inc. develops, manufactures and markets aesthetic treatment systems that enable plastic surgeons, dermatologists and other medical practitioners to perform non-invasive and minimally invasive procedures to remove hair, treat vascular and benign pigmented lesions, remove multi-colored tattoos, revitalize the skin, reduce fat through laser lipolysis, reduce cellulite, clear nails infected by toe fungus, ablate sweat glands and improve women's health. The Company also markets radiofrequency (RF), energy-sourced medical devices for surgical applications, such as facial plastic and general surgery, gynecology, ear, nose, and throat procedures, ophthalmology, oral and maxillofacial surgery, podiatry and proctology. The Company sells its products globally under the Cynosure, Palomar, ConBio and Ellman brand names. Its product portfolio includes single energy source systems, as well as workstations that incorporate two or more different types of lasers or light-based technologies.

Key Stats

• Today's Range: $66.00 to $66.00
• 50-Day Range: N/A
• 52-Week Range: $39.90 to $66.65
• Volume: N/A
• Average Volume: 1.24 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

CYNO Stock Analysis - Frequently Asked Questions

How were Cynosure's earnings last quarter?

Cynosure, Inc. (NASDAQ:CYNO) issued its earnings results on Tuesday, July, 26th. The medical equipment provider reported $0.36 EPS for the quarter, topping the consensus estimate of $0.29 by $0.07. The business's quarterly revenue was up 31.8% on a year-over-year basis.

What other stocks do shareholders of Cynosure own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Cynosure investors own include Global Blood Therapeutics (GBT), Hawkins (HWKN), DHT (DHT), NVIDIA (NVDA), Xtrackers California Municipal Bond ETF (CA), Golar LNG Partners (GMLP) and Micron Technology (MU).

Company Calendar

• Last Earnings: 7/26/2016
• Today: 8/25/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: Health Care Equipment
• Current Symbol: NASDAQ:CYNO
• CIK: 885306
• Web: www.cynosure.com
• Phone: +1-978-2564200
• Fax: N/A
• Employees: N/A
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A